Bionic Pancreas Company Cofounded by BU Researcher Hits the Stock Market
Beta Bionics, the maker of the iLet Bionic Pancreas (an automated insulin delivery device for people with type 1 diabetes) has gone public, allowing anyone to buy shares in the company. The iLet was invented in the Boston University lab of Ed Damiano, a College of Engineering research professor of biomedical engineering, and a cofounder of Beta Bionics. The company hopes going public will help raise funds for product development and infrastructure expansion.
